InvestorsHub Logo
Followers 10
Posts 1040
Boards Moderated 0
Alias Born 07/08/2006

Re: IB_ post# 299220

Tuesday, 08/28/2018 9:26:00 PM

Tuesday, August 28, 2018 9:26:00 PM

Post# of 402142
Nonsense. . .36 or 52 weeks for the Methadone launch? This doesn't even come close to what Nasrat stated during the CC on August 11/2018.

He can still be "correct" if it launch's in 4 weeks or 36 weeks or 52 weeks need I continue ……



"Unidentified Analyst

AND filings, now that Elite have approval for generic Percocet, how soon will you launch? And then, now that Elite has approval for Methadone, how soon would you launch?

Nasrat Hakim

The two parts are very different. For Methadone we intent to launch immediately within the next few weeks, because it’s a smaller product and we started the negotiation with Glenmark while back and already signed the contract. Percocet it’s a much bigger product. So the sales for Methadone, I believe the IMS status about $30 million to $40 million. And for Percocet it's in the hundreds of million, [500 million to 600 million]. So the volume becomes an issue anytime you need evolve and you need the partner that can handle those large quantities. So for Methadone we've already got locked in with the Glenmark and we'll forward within the next few weeks. For Percocet it's probably the next few months."

https://seekingalpha.com/article/4197842-elite-pharmaceuticals-inc-eltp-ceo-nasrat-hakim-q1-2019-results-earnings-call-transcript?part=single
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ELTP News